Patents Assigned to Virago Vax Inc.
  • Mammary tumor virus vaccine
    Patent number: 12029783
    Abstract: Disclosed is a vaccine containing an MTV transition protein. A further version of the invention is a vaccine comprising MTV polypeptides coupled to a carrier protein. MTV may be treated by providing an MTV vaccine with an MTV transition protein; and, administering said vaccine.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: July 9, 2024
    Assignee: VIRAGO VAX INC.
    Inventor: Sophie Bartsich
  • Mammary tumor virus suppression
    Patent number: 12016844
    Abstract: Disclosed are methods of treating a patient exposed to MTV. Also disclosed is a purified cDNA encoding an MTV transition protein peptide chain. Also disclosed is a vaccine containing an MTV transition protein. A further version of the invention is a vaccine comprising MTV polypeptides coupled to a carrier protein. MTV may be treated by providing an MTV vaccine with an MTV transition protein; and, administering said vaccine. In further instances, the MTV vaccine is administered with an antiretroviral medication.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: June 25, 2024
    Assignee: VIRAGO VAX INC.
    Inventor: Sophie Bartsich
  • MAMMARY TUMOR VIRUS SUPPRESSION
    Publication number: 20210000800
    Abstract: Disclosed are methods of treating a patient exposed to MTV. Also disclosed is a purified cDNA encoding an MTV transition protein peptide chain. Also disclosed is a vaccine containing an MTV transition protein. A further version of the invention is a vaccine comprising MTV polypeptides coupled to a carrier protein. MTV may be treated by providing an MTV vaccine with an MTV transition protein; and, administering said vaccine. In further instances, the MTV vaccine is administered with an antiretroviral medication.
    Type: Application
    Filed: July 2, 2020
    Publication date: January 7, 2021
    Applicant: VIRAGO VAX INC.
    Inventor: SOPHIE BARTSICH
  • MAMMARY TUMOR VIRUS VACCINE
    Publication number: 20190343938
    Abstract: Disclosed is a vaccine containing an MTV transition protein. A further version of the invention is a vaccine comprising MTV polypeptides coupled to a carrier protein. MTV may be treated by providing an MTV vaccine with an MTV transition protein; and, administering said vaccine.
    Type: Application
    Filed: July 2, 2019
    Publication date: November 14, 2019
    Applicant: Virago Vax Inc.
    Inventor: Sophie Bartsich